Imaging NFkB Activation in HTLV Lymphoma
Imaging NFkB Activation in HTLV Lymphoma
批准号:
8195497
负责人:
Lee Ratner
金额:
$11.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2016-12-31
关键词:
Animal ModelAnimalsApoptosisAutomobile DrivingBioluminescenceCell LineCell LineageCell SurvivalCellsConcanavalin ADevelopmentFirefly LuciferasesGene TargetingHuman T-Cell Leukemia VirusesIL15 geneImageInflammationInflammatoryInstructionInterleukin-15Knock-outLuminolLymphomaMalignant - descriptorMalignant NeoplasmsMediatingModelingMolecularMonitorMusNeutrophil ActivationNon-MalignantOncogene ProteinsOrder ColeopteraPathogenesisPathway interactionsProliferation MarkerReporterResearchResistanceRoleStagingT-Cell ActivationT-LymphocyteTaxesTransgenic MiceTransgenic OrganismsTransplantationTumor-DerivedUniversitiesWashingtoncancer cellinsightluciferinmolecular imagingmouse modelneoplastic cellprogramspromotertooltumortumor initiationtumorigenesis
中文摘要
该项目将利用生物发光成像(BLI)提供独特的见解的分子
炎症相关癌症的发病机制,与人类T细胞白血病病毒癌蛋白。税在
这些研究我们将使用两种不同的动物模型。首先,我们将分析Tax转基因小鼠,
不同的税务或NFkB BLI记者。其次,我们将分析一个移植模型,其中一个税收
将携带点击甲虫绿色报道基因的转基因细胞系移植到携带NFkB萤火虫的小鼠上
荧光素酶BLI报告基因。我们将回答以下问题:
1)炎症是否通过激活NFkB通路促进淋巴瘤的发生?为此目的,IkB-
Luc小鼠将用于监测具有或不具有T细胞的转基因或移植小鼠中的NFkB活化。
用伴刀豆球蛋白A(conA)激活。将在Rel-A和Rel-B的BLI和IHC之间进行相关性分析。
B NF κ B亚基。
2)哪种NFkB通路在淋巴瘤的恶性和/或非恶性细胞中最重要
发展?为此目的,选择性或经典NFkB缺陷的IKK 1或IKK 2缺失小鼠
将分别在BLI和IHC研究的转基因和移植模型中使用这些途径。
3)NFkB靶基因IL 15在恶性和/或非恶性淋巴瘤中的作用是什么?
恶性细胞?为此目的,我们将IL 15缺失或IL 15野生型Tax淋巴瘤细胞移植到
在IL 15缺失或IL 15野生型动物中测定该关键白细胞介素的浓度,以确定每个细胞中该关键白细胞介素的浓度。
车厢
相关性(参见说明):
总之,这些研究将利用BLI提供更精确的分子描述的作用,
淋巴瘤和微环境中的NFkB活化。
英文摘要
This project will utilize bioluminescence imaging (BLI) to provide unique insights into the molecular
pathogenesis of inflammation-associated cancer, with the human T-cell leukemia virus oncoprotein. Tax. In
these studies we will use two different animal models. First, we will analyze Tax transgenic mice with
different Tax or NFkB BLI reporters. Second, we will analyze a transplantation model in which a Tax
transgenic cell line carrying a click beetle green reporter is grafted onto mice carrying a NFkB firefly
luciferase BLI reporter. We will answer the following questions:
1) Does inflammation promote lymphoma through activation ofthe NFkB pathway? Forthis purpose IkB-
Luc mice will be used to monitor NFkB activation in transgenic or transplanted mice with or without T cell
activation with concanavalin A (con A). Correlation will be perfonned between BLI and IHC of Rel-A and Rel-
B NFkB subunits.
2) Which NFkB pathway is most important in the malignant and/or non-malignant cells for lymphoma
development? Forthis purpose IKK1 or IKK2 deleted mice deficient in the alternative or classical NFkB
pathways, respectively, will be used in the transgenic and transplantation models for BLI and IHC studies.
3) What is the role in lymphoma development of the NFkB-target gene, IL15, in malignant and/or non-
malignant cells? Forthis purpose, we will transplant lL15-deleted or IL15-wild type Tax lymphoma cells into
IL15-deleted or lL15-wild type animals to determine the nale of this critical interieukin in each cellular
compartment.
RELEVANCE (See instructions):
Altogether, these studies will exploit BLI to provide a more refined molecular description ofthe role of
NFkB activation in lymphomas and the microenvironment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
-
批准号:10684172
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2022
-
负责人:Lee Ratner
-
依托单位:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
-
批准号:10518751
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2022
-
负责人:Lee Ratner
-
依托单位:
Interaction of HTLV-1 Tax & Hbz in Transformation
-
批准号:10189192
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2021
-
负责人:Lee Ratner
-
依托单位:
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia
-
批准号:10322134
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2021
-
负责人:Lee Ratner
-
依托单位:
Interaction of HTLV-1 Tax & Hbz in Transformation
-
批准号:10403617
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2021
-
负责人:Lee Ratner
-
依托单位:
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma
-
批准号:10417051
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2021
-
负责人:Lee Ratner
-
依托单位:
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia
-
批准号:10095197
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2021
-
负责人:Lee Ratner
-
依托单位:
Project 4: Tumorigenic Effects of Tax
-
批准号:8742042
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2014
-
负责人:Lee Ratner
-
依托单位:
Developmental Research Program
-
批准号:8595812
-
项目类别:
-
资助金额:$12.33万
-
财政年份:2013
-
负责人:Lee Ratner
-
依托单位:
Developmental Research Program
-
批准号:9093732
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2013
-
负责人:Lee Ratner
-
依托单位:
HIV CORECEPTOR SHIFT
-
批准号:8537609
-
项目类别:
-
资助金额:$21.43万
-
财政年份:2013
-
负责人:Lee Ratner
-
依托单位:
HIV CORECEPTOR SHIFT
-
批准号:8631037
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2013
-
负责人:Lee Ratner
-
依托单位:
CELLULAR RESTRICTIVE FACTOR TARGETED BY VIRAL PROTEIN X
-
批准号:8070291
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2010
-
负责人:Lee Ratner
-
依托单位:
CELLULAR RESTRICTIVE FACTOR TARGETED BY VIRAL PROTEIN X
-
批准号:8197772
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2010
-
负责人:Lee Ratner
-
依托单位:
SIV VPX: STRUCTURE & FUNCTION
-
批准号:7562484
-
项目类别:
-
资助金额:$4.78万
-
财政年份:2007
-
负责人:Lee Ratner
-
依托单位:
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas
-
批准号:7287032
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2007
-
负责人:Lee Ratner
-
依托单位:
MOLECULAR ONCOLOGY TRAINING GRANT
-
批准号:10249193
-
项目类别:
-
资助金额:$26.57万
-
财政年份:2006
-
负责人:Lee Ratner
-
依托单位:
Molecular Oncology Training Grant
-
批准号:7006693
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2006
-
负责人:Lee Ratner
-
依托单位:
Molecular Oncology Training Grant
-
批准号:8551635
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2006
-
负责人:Lee Ratner
-
依托单位:
Molecular Oncology Training Grant
-
批准号:9523043
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2006
-
负责人:Lee Ratner
-
依托单位:
海外基金